London Institute for Healthcare Engineering logoLondon Institute for Healthcare Engineering logo

MedTech Venture Builder Collaborative Centre of Excellence

Starting July 2024

The MedTech Venture Builder (MVB) is a 12-month structured programme in two stages to help accelerate the translation of promising medical technologies into robust, investment-ready healthcare ventures.

Apply now!

Supporting companies from across the UK, the MVB, the first of its kind, is a collaborative effort between London’s leading academic institutions, King’s College London (lead), Queen Mary University London, City, University of London, and St. George’s University London.

King's College London, Queen Mary University of London, City, University of London, St George's University of London logos

Our collaborative focus on MedTech allows us to take ventures a significant step further than what has been achieved before programmatically. We will provide the structures that are critical to a robust MedTech company, such as a regulatory plan, a clinical evidence roadmap and stakeholder mapping, extensive hands- on guidance and monthly strategic progress review, all within a fit-for-purpose Quality Management System (QMS).

This is a truly unique opportunity for very select, high-potential MedTech companies from across the UK to receive fully customised, extensive executive support from experts in commercial translation from the partner institutions.

This is only possible with the support of a significant grant by Research England for a Collaborative Centre of Excellence (CCoE) for MedTech translation.


LIHE building

What we offer

Space at King’s London Institute for Healthcare Engineering for up to 4 team members per venture for the duration of the programme.

Stage 1 (6-month duration): Gearing up

  1. £20,000 grant funding to the founding academic institution of each venture to be used as needed for the venture (note this grant is only available to spin-outs/startups from academic institutions)
  2. Hands-on strategic milestone development, validation of the business case, and familiarisation with the rigorous tools, processes and methods of an established MedTech company with industry experts

Stage 2 (6-month duration): Venture Building for value inflection

  1. Development of a regulatory plan with hands-on expert support
  2. Access to an ISO13485 Quality Management System, and hands-on support to develop a technical file towards regulatory submission
  3. Health technology assessment to generate a robust value proposition for the venture’s offering, with identified stakeholders
  4. Generation of a clinical protocol for clinical studies/trials (where applicable and deemed feasible by the Venture Builder experts)
  5. Investor engagement, pitch preparation and showcase event
  6. Ongoing community support post-programme
People speaking in amongst a crowd

Key outcomes

By participating in the MedTech Venture Builder your venture will:

  1. Have moved to its next value inflection point in commercial MedTech terms
  2. Have validated and strengthened its technology's commercial viability
  3. Have systematically advanced towards being a compliant, seed-ready healthcare venture
  4. Transferred core skills in MedTech processes and rigour to founders and/or execs
  5. Construct regulatory plan and critical documentation from a Quality Management System
  6. Prepared fundraising materials and pitches
  7. Expanded networks with industry partners and investors


The MedTech Venture Builder invites applications from:

  • A small number of companies applying from across the UK will be selected to participate
  • Medical technology spinouts from any of the 4 consortium partner institutions
  • Software as a Medical Device (SaMD) applications are welcome

Minimum requirements to apply

  • Technologies should be at minimum proof of concept stage with initial evidence
  • Institutional or non-institutional intellectual property
  • Approval from founding institution (where applicable) to participate
  • Agnostic on funding stage

Additional requirements

  • Cross-functional leadership team in place with complementary skill sets
  • Shareholding agreed between founders, including with the founding academic institution (or assurances by the institution and the founders to this effect)
  • Commitment of founders to explore commercialisation and translate technology to patient impact (if not incorporated)
  • Availability to participate during the entirety of the 12-month programme, which will typically require 1-2 days commitment per week

Programme dates

  • Applications close on Tuesday 21st of May 23.59 BST
  • Interviews to be held w/c 3rd of June
  • Programme starts w/c 1st of July

LIHE is the latest trailblazing initiative from King’s College London

London Institute for Healthcare Engineering logoKing's College London logoUKRI Research England logoKing's Health Partners logo